NAT2 and colorectal carcinoma: Although no correlation between NAT2 phenotypes and CRC risk was found pooling the data from 6 studies which stratified smoking status, a precise measurement of exposure to carcinogens may be helpful to understand the biological mechanisms when genes involved in metabolic pathways are assessed.